DXCM DexCom, Inc. - Common Stock
$90,75
Fiyat · Ağu 18, 2026
Temel veriler itibarıyla Tem 30, 2026
52 Haftlık Aralık
$54–$92
97% of range
Analist Derecelendirmesi
BUY
36 analysts
Fiyat Hedefi
$93
+3% upside
P/E (TTM)
43.5
ROE
31.4%
Net Kâr Marjı
17.9%
DexCom, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
Devamını oku
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
History
Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. In 2006, Dexcom received U.S. Food and Drug Administration (FDA) approval and launched the Dexcom STS Continuous Glucose Monitoring System, which is a three-day sensor that provides up to 288 glucose measurements for every 24 hours. Dexcom received approval of the second-generation product, the Seven Continuous Glucose Monitoring System, in May 2007. This device improved on accuracy and extended use from three to seven days. In 2008, Dexcom announced two consumer development agreements with Insulet Corporation and Animas Corporation as well as a development agreement with Edwards Lifesciences for a continuous glucose monitor in the intensive care unit hospital environment.
During February 2009, Dexcom received approval for the Seven Plus Continuous Glucose Monitor, its new continuous glucose monitoring system, from the FDA. This product received a CE mark in November 2009. In 2013, development work for integration with Insulet was discontinued. Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its forthcoming G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. The G5 was approved in 2016 by the FDA for use as a standalone device, while the G6 gained approval in 2018.
Dexcom's first G-series CGM, the G4 Platinum, received a CE mark and FDA approval in 2012 for adults ages 18 and over. This device improved hypoglycemic accuracy by 30%. It also offered a longer range of transmission between the sensor and receiver, as well as a color LCD. The G4 Platinum was approved by the FDA for use in patients ages 2–17 in February 2014. Dexcom received FDA approval in January 2015 for the G4 Platinum with Share, which enabled the sharing of CGM data with up to five other people using the "Share" and "Follow" smartphone apps.
The Dexcom G5 was approved in August 2015 by the FDA for use as a standalone device, the G5 has Bluetooth integrated into its transmitter, enabling it to send data to a mobile device. This allows for use of the device without the standalone receiver. The Dexcom G5 received a CE mark in September 2015.
Dexcom went public in 2005 and is listed on the Nasdaq Global Select Market stock exchange under the ticker symbol DXCM. On April 20, 2020, Dexcom became a component of the Nasdaq-100, replacing American Airlines Group in the index.
The Dexcom G7 was approved in December 2022 by the FDA for use as a standalone device. The Dexcom G7 15-Day is the most accurate currently approved CGM in the U.S.
Awards and recognition
In October 2024, Time Magazine named Dexcom Stelo's over-the-counter glucose monitor one of the year's best inventions.
Partnerships
Dexcom entered into a partnership in 2015 with Google Life Sciences (which subsequently became Verily) to develop the Dexcom G7
Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its new G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. Tandem Diabetes Care received FDA approval in December 2019 for Control-IQ, a closed-loop technology that uses Tandem's t:slim X2 insulin pump and the Dexcom G6 "to automatically increase, decrease, or stop the delivery of insulin in response to the glucose levels of people with Type 1 diabetes."
In June 2019, Dexcom announced a collaboration with Companion Medical to enable the exchange of CGM data from Dexcom with insulin data from InPen into both companies' software applications.
Dexcom entered into a partnership with Livongo, a digital chronic care management company, in January 2020 to share CGM data from the Dexcom G6 with Livongo's platform. This integration allowed Livongo to incorporate the CGM data along with other patient data.
In February 2020, Dexcom and Insulet Corporation signed a non-exclusive, global agreement to combine current and future Dexcom continuous glucose monitoring systems with Insulet's tubeless insulin delivery Pod into the Omnipod Horizon System for automated insulin delivery. This allowed the ability to adjust insulin doses based on Insulet's algorithm or through their smartphone.
The company also announced in March 2020 a partnership with Welldoc to integrate G6 CGM data with BlueStar, a digital platform for diabetes management.
In November 2024, Dexcom announced a "strategic partnership" and data exchange with Oura.
Venture capital arm
In early 2021, Dexcom launched Dexcom Ventures, a venture capital arm focused on emerging continuous glucose monitoring technologies and devices measuring the levels of other types of substances and analytes. In practice, Dexcom Ventures has also invested in cybersecurity platforms for the software used in medical devices.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
DXCM Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$90.75
Piyasa Değeri
$35.02B
P/E (TTM)
43.5
EPS (TTM)
$2.09
Gelir (TTM)
$4.66B
Temettü Verimi
—
ROE
31.4%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$54 – $92
DXCM Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$4.66B
2016-12-31
→
2025-12-31
Hisse Başına Kâr
$2.09
2017-12-31
→
2025-12-31
Serbest Nakit Akışı
$1.08B
2016-12-31
→
2025-12-31
Marjlar
17.9%
2018-12-31
→
2025-12-31
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
DXCM
Akran Ortalaması
P/E (TTM)
43.5
26.3
P/S (TTM) (F/S (TTM))
7.5
4.4
P/B (F/D)
12.8
5.3
Price / FCF (Fiyat / Serbest Nakit Akışı)
32.5
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
DXCM
Akran Ortalaması
Gross Margin (Brüt Kar Marjı)
60.1%
63.1%
Operating Margin (Faaliyet Kâr Marjı)
19.6%
—
Net Profit Margin (Net Kâr Marjı)
17.9%
15.6%
ROA
13.0%
7.6%
ROE
31.4%
15.0%
ROIC
25.5%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
DXCM
Akran Ortalaması
Current Ratio (Cari Oran)
1.9
1.7
Quick Ratio (Cari Oran)
1.0
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
DXCM
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
15.6%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
17.0%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
19.3%
—
EPS YoY (EPS YB)
47.2%
—
Net Income YoY (Net Gelir Yıllık Bazda)
45.1%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
DXCM
Akran Ortalaması
DXCM Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
36 analist
- Güçlü Al 15 41,7%
- Al 16 44,4%
- Tut 5 13,9%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
25 analist · 2026-08-14
Medyan
$93.00
Şimdi
$90.75
Düşük
$79.00
Yüksek
$115.00
Medyan hedef
$93.00
+2,5%
Ortalama hedef
$93.44
+3,0%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.05%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $0.70 | $0.62 | 0.08% |
| 31 Mart 2026 | $0.56 | $0.48 | 0.08% |
| 31 Aralık 2025 | $0.56 | $0.48 | 0.08% |
| 30 Eylül 2025 | $0.61 | $0.58 | 0.03% |
| 30 Haziran 2025 | $0.48 | $0.45 | 0.03% |
| 31 Mart 2025 | $0.32 | $0.33 | -0.01% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | — | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| BDX | — | 25.3 | 8.2% | 7.7% | 6.5% | — |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 18
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | · | · | |
| Cost of Revenue | $1.86B | $1.59B | $1.33B | $1.03B | $768M | $647M | $544M | $368M | $226M | $195M | $124M | $83M | |
| Gross Profit | $2.80B | $2.44B | $2.29B | $1.88B | $1.68B | $1.28B | $932M | $664M | $492M | $378M | $278M | $176M | |
| R&D Expense | $599M | $552M | $506M | $484M | $517M | $360M | $274M | $200M | $185M | $156M | $138M | $69M | |
| SG&A Expense | $1.29B | $1.29B | $1.19B | $1.01B | $810M | $618M | $516M | $433M | $349M | $286M | $198M | $128M | |
| Operating Expenses | $1.89B | $1.84B | $1.69B | $1.49B | $1.41B | $981M | $789M | $850M | $535M | $442M | $336M | $198M | |
| Operating Income | $912M | $600M | $598M | $391M | $266M | $300M | $142M | $-186M | $-42M | $-64M | $-57M | $-22M | |
| Interest Expense | · | · | $20M | $19M | $19M | $18M | $60M | $23M | $13M | $700.0K | $400.0K | $800.0K | |
| Interest Income | · | · | · | · | · | · | · | · | $3M | $400.0K | $0 | $0 | |
| Other Non-op | $177M | $109M | $113M | $-400.0K | $-9M | $16M | $26M | $2M | $7M | $-700.0K | $0 | $0 | |
| Pretax Income | $1.09B | $709M | $710M | $391M | $257M | $298M | $104M | $-126M | $-49M | $-65M | $-58M | $-22M | |
| Income Tax | $252M | $133M | $169M | $50M | $40M | $-252M | $3M | $600.0K | $2M | $700.0K | $100.0K | $100.0K | |
| Net Income | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| EPS (Basic) | $2.14 | $1.46 | $1.40 | $0.88 | $0.56 | $1.46 | $1.11 | $-1.44 | $-0.58 | · | · | · | |
| EPS (Diluted) | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 | $1.33 | $1.10 | $-1.44 | $-0.58 | · | · | · | |
| Shares (Basic) | 390,200,000 | 393,600,000 | 386,000,000 | 389,400,000 | 386,900,000 | 377,500,000 | 91,100,000 | 88,200,000 | 86,300,000 | · | · | · | |
| Shares (Diluted) | 405,500,000 | 412,700,000 | 425,500,000 | 427,500,000 | 428,800,000 | 420,400,000 | 92,300,000 | 88,200,000 | 86,300,000 | · | · | · | |
| EBITDA | $1.16B | $818M | $784M | $547M | $368M | $367M | $191M | $-157M | $-26M | $-49M | $-46M | $-13M |
Bilanço 26
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $918M | $606M | $566M | $642M | $1.05B | $818M | $446M | $1.14B | $442M | $94M | $86M | $72M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $93M | $23M | · | · | |
| Receivables | $1.22B | $1.01B | $974M | $713M | $514M | $428M | $286M | $227M | $134M | $102M | $74M | $42M | |
| Inventory | $629M | $543M | $560M | $307M | $357M | $235M | $120M | $71M | $45M | $45M | $35M | $16M | |
| Prepaid Expense | $189M | $174M | $168M | $193M | $82M | $54M | $30M | $16M | $17M | $9M | $7M | $4M | |
| Other Current Assets | $29M | $29M | $49M | $27M | $27M | · | · | · | · | · | · | · | |
| Current Assets | $4.03B | $4.30B | $4.43B | $3.67B | $3.68B | $3.42B | $1.97B | $1.70B | $745M | $280M | $231M | $146M | |
| PP&E (Net) | · | · | · | $1.06B | $802M | $515M | $321M | $183M | $146M | $109M | $55M | $31M | |
| PP&E (Gross) | · | · | · | $1.42B | $1.03B | $670M | $426M | $263M | $200M | $157M | $93M | $64M | |
| Accum. Depreciation | · | · | · | $363M | $232M | $154M | $105M | $80M | $55M | $47M | $38M | $33M | |
| Goodwill | $24M | $23M | $25M | $26M | $26M | $19M | $19M | $19M | $12M | $11M | $4M | $3M | |
| Intangibles | $71M | $103M | $134M | $173M | $32M | · | · | · | · | $200.0K | $2M | $3M | |
| Other Non-current Assets | $279M | $173M | $75M | $47M | $10M | $21M | $14M | $15M | $2M | $2M | $100.0K | $600.0K | |
| Total Assets | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Current Liabilities | $2.14B | $2.93B | $1.56B | $1.84B | $721M | $614M | $360M | $222M | $139M | $102M | $67M | $41M | |
| Capital Leases | $73M | $65M | $80M | $95M | $99M | $102M | $72M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | $5M | $6M | $0 | · | · | · | · | · | · | |
| Other Non-current Liabilities | $137M | $148M | $126M | $128M | $90M | $81M | $20M | $20M | $18M | $17M | $4M | $2M | |
| Total Liabilities | $3.59B | $4.38B | $4.20B | $3.26B | $2.89B | $2.46B | $1.51B | $1.25B | $485M | $119M | $71M | $44M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $5M | |
| Retained Earnings | $2.43B | $1.60B | $1.02B | $480M | $139M | $-78M | $-696M | $-799M | $-672M | $-621M | $-555M | $-498M | |
| Treasury Stock | $2.08B | $1.58B | $2.45B | $595M | $206M | $100M | $100M | $100M | $0 | · | · | · | |
| AOCI | $115M | $-8M | $-17M | $-12M | $500.0K | $3M | $2M | $2M | $-3M | $-1M | $-300.0K | $-100.0K | |
| Stockholders' Equity | $2.75B | $2.10B | $2.07B | $2.13B | $2.04B | $1.55B | $883M | $663M | $419M | $284M | $221M | $140M | |
| Liabilities + Equity | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Shares Outstanding | 384,800,000 | 390,700,000 | 385,400,000 | 386,300,000 | 388,000,000 | 384,400,000 | 366,400,000 | 90,000,000 | 87,000,000 | 84,600,000 | 81,700,000 | 77,300,000 |
Nakit Akışı 19
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $252M | $218M | $186M | $156M | $102M | $67M | $49M | $29M | $16M | $15M | $11M | $8M | |
| Stock-based Comp | $160M | $170M | $151M | $126M | $113M | $119M | $103M | $102M | $106M | $111M | $83M | $50M | |
| Deferred Tax | $182M | $-44M | $-55M | $-22M | $16M | $-260M | $200.0K | $-2M | $0 | $-200.0K | $0 | $0 | |
| Amort. of Intangibles | $4M | $7M | $8M | $8M | $4M | $2M | · | · | · | $700.0K | $500.0K | $600.0K | |
| Restructuring | · | · | · | · | · | · | $8M | · | · | · | · | · | |
| Other Non-cash | $11M | $69M | $-75M | $68M | $77M | $73M | $62M | $122M | $20M | $-4M | $13M | $-12M | |
| Operating Cash Flow | $1.44B | $990M | $748M | $670M | $442M | $476M | $314M | $123M | $92M | $56M | $49M | $24M | |
| CapEx | $364M | $359M | $237M | $365M | $389M | $199M | $180M | $67M | $66M | $56M | $33M | $16M | |
| Investing Cash Flow | $536M | $-208M | $-507M | $-522M | $-216M | $-1.02B | $-1.02B | $-140M | $-144M | $-56M | $-52M | $-17M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $0 | $-2M | $-2M | $-2M | |
| Stock Issued | $28M | $28M | $27M | $22M | $20M | $15M | $12M | $11M | $10M | $10M | $19M | $24M | |
| Stock Repurchased | $500M | $750M | $689M | $558M | $0 | $0 | $0 | $100M | $0 | $0 | · | · | |
| Net Stock Activity | $-472M | $-722M | $-662M | $-535M | $20M | $15M | $12M | $-89M | $10M | $10M | $19M | $24M | |
| Financing Cash Flow | $-1.69B | $-735M | $-319M | $-552M | $10M | $912M | $11M | $710M | $399M | $8M | $17M | $22M | |
| Net Change in Cash | $312M | $40M | $-76M | $-410M | $235M | $372M | $-691M | $696M | $347M | $8M | $14M | $29M | |
| Taxes Paid | $94M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.08B | $631M | $512M | $305M | $53M | $277M | $134M | $56M | $26M | $500.0K | $16M | $7M | |
| Levered FCF | · | · | $496M | $288M | $-36M | $91M | $76M | $33M | $13M | $-207.6K | $15M | $7M |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% | 66.4% | 63.1% | 64.4% | · | · | · | · | |
| Operating Margin | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% | 15.5% | 9.6% | -18.1% | · | · | · | · | |
| Net Margin | 17.9% | 14.3% | 14.9% | 11.7% | 6.3% | 25.6% | 6.9% | -12.3% | · | · | · | · | |
| Pretax Margin | 23.4% | 17.6% | 19.6% | 13.4% | 7.1% | 11.7% | 7.1% | -12.3% | · | · | · | · | |
| EBITDA Margin | 25.0% | 20.3% | 21.6% | 18.8% | 15.0% | 19.0% | 12.9% | -15.2% | · | · | · | · | |
| ROA | 13.0% | 9.0% | 9.3% | 6.6% | 3.4% | 14.8% | 4.7% | -9.0% | -7.7% | -18.9% | -24.2% | -14.6% | |
| ROE | 31.4% | 28.2% | 25.0% | 17.2% | 7.4% | 29.7% | 12.3% | -20.7% | -14.3% | -26.0% | -31.9% | -20.0% | |
| ROIC | 25.5% | 23.2% | 22.0% | 16.0% | 10.5% | 36.0% | 15.6% | -28.2% | -10.5% | -22.8% | -25.9% | -15.4% |
Likidite ve Solventlik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 | 5.6 | 5.5 | 7.6 | 5.4 | 2.7 | 3.5 | 3.6 | |
| Quick Ratio | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 | 2.0 | 2.0 | 6.1 | 4.8 | 2.1 | 2.4 | 1.8 | |
| Interest Coverage | · | · | 29.4 | 21.0 | 2.6 | 3.5 | 2.4 | -8.2 | -3.3 | -91.3 | -142.8 | -26.9 |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.7 | 0.7 | · | · | · | · | |
| Inventory Turnover | 3.2 | 2.9 | 3.1 | 3.1 | 2.6 | 3.6 | 5.7 | 6.3 | 5.0 | 4.8 | 4.8 | 6.6 | |
| Receivables Turnover | 4.2 | 4.1 | 4.3 | 4.7 | 5.2 | 5.4 | 5.8 | 5.7 | · | · | · | · |
Büyüme Oranları 9
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 15.6% | 11.3% | 24.5% | 18.8% | 27.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 17.0% | 18.1% | 23.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 47.2% | 9.2% | 58.5% | 54.7% | -60.2% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 36.6% | 38.9% | -0.76% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 45.1% | 6.4% | 58.7% | 57.3% | -60.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 34.8% | 38.5% | -0.50% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 8.8% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | $402M | $259M | |
| Net Income TTM | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| Market Cap | $25.54B | $30.38B | $47.82B | $43.74B | $13.02B | $8.88B | $5.01B | $2.70B | $1.25B | $1.26B | $1.67B | $1.06B | |
| P/E | 31.8 | 54.8 | 95.5 | 138.1 | 253.3 | 69.5 | 49.7 | -20.8 | -24.7 | · | · | · | |
| P/S | 5.5 | 7.5 | 13.2 | 15.0 | 5.3 | 4.6 | 3.4 | 2.6 | 1.7 | 2.2 | 4.2 | 4.1 | |
| P/B | 9.3 | 14.5 | 23.1 | 20.5 | 5.8 | 4.9 | 5.7 | 4.1 | 3.0 | 4.4 | 7.6 | 7.6 | |
| P / Tangible Book | 9.6 | 15.4 | 25.1 | 22.6 | 6.6 | 5.8 | · | · | · | · | · | · | |
| P / Cash Flow | 17.7 | 30.7 | 63.9 | 65.3 | 29.4 | 18.7 | 15.9 | 21.9 | 13.6 | 22.5 | 34.1 | 45.1 | |
| P / FCF | 23.7 | 48.2 | 93.4 | 143.6 | 244.3 | 32.1 | 37.2 | 48.0 | 48.0 | 2525.3 | 106.5 | 143.8 | |
| Earnings Yield | 3.1% | 1.8% | 1.1% | 0.72% | 0.39% | 1.4% | 2.0% | -4.8% | -4.0% | · | · | · |
Gelir Tablosu 17
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.31B | $1.19B | $1.26B | $1.21B | $1.16B | $1.04B | $1.11B | $994M | $1.00B | $921M | $1.03B | $975M | $871M | $742M | $815M | $770M | |
| Cost of Revenue | $478M | $442M | $467M | $478M | $468M | $447M | $458M | $400M | $378M | $359M | $378M | $352M | $325M | $279M | $274M | $275M | |
| Gross Profit | $830M | $750M | $793M | $731M | $689M | $589M | $656M | $594M | $627M | $562M | $657M | $623M | $546M | $463M | $541M | $494M | |
| R&D Expense | $153M | $145M | $148M | $158M | $148M | $145M | $140M | $135M | $136M | $142M | $136M | $131M | $119M | $119M | $116M | $110M | |
| SG&A Expense | $359M | $350M | $322M | $331M | $328M | $310M | $327M | $306M | $333M | $319M | $304M | $286M | $299M | $296M | $305M | $235M | |
| Operating Expenses | $512M | $495M | $470M | $489M | $476M | $455M | $467M | $442M | $469M | $461M | $440M | $418M | $418M | $415M | $416M | $347M | |
| Operating Income | $318M | $255M | $323M | $242M | $213M | $134M | $189M | $152M | $158M | $101M | $217M | $206M | $128M | $47M | $125M | $148M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $5M | · | $5M | $6M | $5M | · | $5M | |
| Other Non-op | $-800.0K | $14M | $18M | $110M | $28M | $21M | $22M | $25M | $30M | $31M | $29M | $35M | $31M | $17M | $-1M | $-1M | |
| Pretax Income | $318M | $270M | $341M | $352M | $241M | $154M | $211M | $177M | $188M | $132M | $246M | $240M | $159M | $64M | $133M | $146M | |
| Income Tax | $68M | $70M | $73M | $68M | $61M | $49M | $60M | $43M | $44M | $-14M | $-10M | $120M | $43M | $16M | $41M | $45M | |
| Net Income | $249M | $200M | $267M | $284M | $180M | $105M | $152M | $135M | $144M | $146M | $256M | $121M | $116M | $49M | $92M | $101M | |
| EPS (Basic) | $0.65 | $0.52 | $0.68 | $0.73 | $0.46 | $0.27 | $0.38 | $0.34 | $0.36 | $0.38 | $0.66 | $0.31 | $0.30 | $0.13 | $0.24 | $0.26 | |
| EPS (Diluted) | $0.64 | $0.51 | $0.67 | $0.70 | $0.45 | $0.27 | $0.37 | $0.34 | $0.35 | $0.36 | $0.61 | $0.29 | $0.28 | $0.12 | $0.23 | $0.24 | |
| Shares (Basic) | 382,200,000 | 385,100,000 | -784,100,000 | 391,100,000 | 392,100,000 | 391,100,000 | -790,000,000 | 394,200,000 | 399,200,000 | 390,200,000 | -774,000,000 | 386,600,000 | 386,700,000 | 386,700,000 | -781,800,000 | 389,800,000 | |
| Shares (Diluted) | 390,100,000 | 393,600,000 | -817,600,000 | 407,400,000 | 408,200,000 | 407,500,000 | -831,000,000 | 410,200,000 | 416,800,000 | 416,700,000 | -851,300,000 | 426,800,000 | 431,500,000 | 418,500,000 | -848,400,000 | 425,800,000 | |
| EBITDA | $386M | $322M | · | $306M | $276M | $194M | · | $152M | $158M | $154M | · | $206M | $128M | $89M | · | $148M |
Bilanço 24
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.10B | $1.12B | $918M | $1.84B | $1.16B | $905M | $606M | $621M | $939M | $851M | $566M | $644M | $1.19B | $623M | $642M | $698M | |
| Receivables | $1.26B | $1.09B | $1.22B | $1.11B | $1.35B | $1.16B | $1.01B | $1.00B | $945M | $979M | · | $786M | $751M | $637M | · | $564M | |
| Inventory | $726M | $694M | $629M | $604M | $571M | $538M | $543M | $586M | $570M | $589M | · | $499M | $421M | $366M | · | $311M | |
| Prepaid Expense | $156M | $134M | $189M | $184M | $181M | $159M | $174M | $182M | $212M | $156M | · | $174M | $195M | $198M | · | $152M | |
| Other Current Assets | $37M | $30M | $29M | $34M | $46M | $43M | $29M | $48M | $48M | $40M | · | $41M | $58M | $43M | · | $28M | |
| Current Assets | $4.09B | $4.33B | $4.03B | $5.22B | $5.03B | $4.55B | $4.30B | $4.26B | $4.85B | $4.62B | · | $4.70B | $5.00B | $3.77B | · | $3.40B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.08B | · | $1.00B | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.47B | · | $1.34B | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $394M | · | $338M | |
| Goodwill | $24M | $24M | $24M | $24M | $24M | $23M | $23M | $24M | $23M | $23M | · | $25M | $26M | $26M | · | $25M | |
| Intangibles | $102M | $63M | $71M | $79M | $87M | $95M | $103M | $106M | $114M | $123M | · | $144M | $154M | $164M | · | $24M | |
| Other Non-current Assets | $274M | $286M | $279M | $276M | $176M | $168M | $173M | $88M | $83M | $78M | · | $74M | $67M | $57M | · | $34M | |
| Total Assets | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Current Liabilities | $2.36B | $2.22B | $2.14B | $3.34B | $3.31B | $3.04B | $2.93B | $1.73B | $1.72B | $1.59B | · | $1.68B | $2.07B | $1.86B | · | $900M | |
| Capital Leases | $83M | $69M | $73M | $51M | $55M | $60M | $65M | $71M | $77M | $76M | · | $83M | $87M | $90M | · | $82M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $5M | $5M | $5M | · | $5M | |
| Other Non-current Liabilities | $151M | $142M | $137M | $147M | $152M | $150M | $148M | $130M | $128M | $129M | · | $134M | $133M | $130M | · | $123M | |
| Total Liabilities | $3.83B | $3.68B | $3.59B | $4.77B | $4.75B | $4.49B | $4.38B | $4.37B | $4.36B | $4.24B | · | $4.33B | $4.72B | $3.28B | · | $3.07B | |
| Retained Earnings | $2.88B | $2.63B | $2.43B | $2.17B | $1.88B | $1.70B | $1.60B | $1.45B | $1.31B | $1.17B | · | $765M | $644M | $528M | · | $388M | |
| Treasury Stock | $2.73B | $2.12B | $2.08B | $1.77B | $1.58B | $1.58B | $1.58B | $1.58B | $832M | $1.39B | · | $2.08B | $784M | $595M | · | $595M | |
| AOCI | $90M | $106M | $115M | $82M | $84M | $2M | $-8M | $63M | $-38M | $-37M | · | $-36M | $-29M | $-6M | · | $-41M | |
| Stockholders' Equity | $2.62B | $2.96B | $2.75B | $2.73B | $2.57B | $2.27B | $2.10B | $1.98B | $2.43B | $2.25B | $2.07B | $2.27B | $2.10B | $2.23B | $2.13B | $1.82B | |
| Liabilities + Equity | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Shares Outstanding | 377,400,000 | 385,900,000 | 384,800,000 | 390,000,000 | 392,200,000 | 392,100,000 | 390,700,000 | 390,600,000 | 400,700,000 | 396,100,000 | 385,400,000 | 386,400,000 | 386,100,000 | 387,600,000 | 386,300,000 | 386,200,000 |
Nakit Akışı 15
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $68M | $67M | $65M | $64M | $63M | $60M | $58M | $55M | $52M | $52M | $52M | $48M | $44M | $42M | $36M | $39M | |
| Stock-based Comp | $39M | $43M | $35M | $45M | $45M | $34M | $43M | $43M | $45M | $39M | $37M | $39M | $40M | $35M | $34M | $31M | |
| Deferred Tax | $-300.0K | $300.0K | $79M | $118M | $-9M | $-6M | $24M | $-12M | $-15M | $-42M | $82M | $-85M | $-42M | $-9M | $32M | $-34M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-cash | · | $215M | · | · | · | $-10M | · | · | · | $13M | · | · | · | $39M | · | · | |
| Operating Cash Flow | $269M | $526M | $294M | $660M | $303M | $184M | $301M | $200M | $279M | $209M | $134M | $269M | $190M | $155M | $132M | $293M | |
| CapEx | $85M | $77M | $102M | $80M | $94M | $87M | $125M | $111M | $66M | $57M | $52M | $50M | $59M | $75M | $64M | $108M | |
| Investing Cash Flow | $330M | $-298M | $307M | $193M | $-64M | $100M | $-304M | $210M | $-189M | $75M | $415M | $-180M | $-556M | $-187M | $-194M | $229M | |
| Stock Issued | $0 | $13M | $0 | $14M | $0 | $14M | $0 | $15M | $0 | $13M | $0 | $14M | $0 | $12M | $0 | $12M | |
| Stock Repurchased | · | · | $313M | $187M | · | · | $0 | $750M | · | · | $500M | $0 | · | · | $0 | $558M | |
| Net Stock Activity | · | $13M | · | · | · | $14M | · | · | · | $13M | · | · | · | $12M | · | · | |
| Financing Cash Flow | $-607M | $-25M | $-1.52B | $-175M | $-2M | $12M | $-2M | $-736M | $-1M | $5M | $-632M | $-637M | $940M | $11M | $-1M | $-552M | |
| Net Change in Cash | $-13M | $199M | $-918M | $677M | $254M | $299M | $-15M | $-318M | $88M | $285M | $-77M | $-551M | $572M | $-19M | $-56M | $-37M | |
| Free Cash Flow | · | $449M | · | · | · | $97M | · | · | · | $152M | · | · | · | $81M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $147M | · | · | · | $77M | · | · |
Kârlılık 8
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.4% | 62.9% | · | 60.5% | 59.5% | 56.9% | · | 59.7% | 62.4% | 61.0% | · | 63.9% | 62.7% | 62.4% | · | 64.2% | |
| Operating Margin | 24.3% | 21.4% | · | 20.1% | 18.4% | 12.9% | · | 15.3% | 15.7% | 11.0% | · | 21.1% | 14.7% | 6.4% | · | 19.2% | |
| Net Margin | 19.0% | 16.7% | · | 23.5% | 15.5% | 10.2% | · | 13.5% | 14.3% | 15.9% | · | 12.4% | 13.3% | 6.6% | · | 13.2% | |
| Pretax Margin | 24.3% | 22.6% | · | 29.1% | 20.8% | 14.9% | · | 17.8% | 18.7% | 14.4% | · | 24.7% | 18.3% | 8.7% | · | 19.0% | |
| EBITDA Margin | 29.5% | 27.1% | · | 25.3% | 23.8% | 18.7% | · | 15.3% | 15.7% | 16.7% | · | 21.1% | 14.7% | 12.0% | · | 19.2% | |
| ROA | 3.6% | 3.0% | · | 4.1% | 2.5% | 1.6% | · | 2.1% | 2.1% | 2.4% | · | 2.1% | 1.9% | 0.92% | · | 2.1% | |
| ROE | 9.6% | 7.6% | · | 12.1% | 7.2% | 4.7% | · | 6.3% | 6.3% | 6.5% | · | 5.9% | 5.3% | 2.2% | · | 5.1% | |
| ROIC | 9.5% | 6.4% | · | 7.2% | 6.2% | 4.0% | · | 5.8% | 5.0% | 5.0% | · | 4.5% | 4.4% | 1.6% | · | 5.6% |
Likidite ve Solventlik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 1.6 | 1.5 | 1.5 | · | 2.5 | 2.8 | 2.9 | · | 2.8 | 2.4 | 2.0 | · | 3.8 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.9 | 0.8 | 0.7 | · | 0.9 | 1.1 | 1.1 | · | 0.9 | 0.9 | 0.7 | · | 1.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 22.0 | · | 41.9 | 21.7 | 10.3 | · | 32.1 |
Verimlilik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.8 | 0.8 | 0.8 | · | 0.7 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.8 | · | 0.8 | |
| Receivables Turnover | 1.0 | 1.1 | · | 1.1 | 1.0 | 1.0 | · | 1.1 | 1.2 | 1.1 | · | 1.4 | 1.3 | 1.3 | · | 1.4 |
Değerleme (TTM) 10
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.87B | $4.59B | · | $4.40B | $4.19B | $3.96B | · | $3.89B | $3.77B | $3.51B | · | $3.36B | $3.08B | $2.84B | · | $2.74B | |
| Net Income TTM | $912M | $768M | · | $704M | $563M | $530M | · | $545M | $526M | $432M | · | $386M | $317M | $298M | · | $337M | |
| Market Cap | $25.42B | $24.23B | · | $26.24B | $34.24B | $26.78B | · | $26.19B | $45.43B | $54.94B | · | $36.05B | $49.62B | $45.03B | · | $31.10B | |
| P/E | 29.3 | 32.5 | · | 38.2 | 61.9 | 51.7 | · | 50.0 | 88.6 | 132.1 | · | 100.3 | 169.1 | 163.6 | · | 100.7 | |
| P/S | 5.2 | 5.3 | · | 6.0 | 8.2 | 6.8 | · | 6.7 | 12.0 | 15.7 | · | 10.7 | 16.1 | 15.9 | · | 11.3 | |
| P/B | 9.7 | 8.2 | · | 9.6 | 13.3 | 11.8 | · | 13.2 | 18.7 | 24.5 | · | 15.9 | 23.6 | 20.2 | · | 17.0 | |
| P / Tangible Book | 10.2 | 8.4 | · | 10.0 | 13.9 | 12.5 | · | 14.2 | 19.8 | 26.2 | · | 17.2 | 25.8 | 22.0 | · | 17.5 | |
| P / Cash Flow | · | 46.1 | · | · | · | 145.7 | · | · | · | 262.6 | · | · | · | 289.8 | · | · | |
| P / FCF | · | 54.0 | · | · | · | 276.6 | · | · | · | 360.7 | · | · | · | 558.0 | · | · | |
| Earnings Yield | 3.4% | 3.1% | · | 2.6% | 1.6% | 1.9% | · | 2.0% | 1.1% | 0.76% | · | 1.0% | 0.59% | 0.61% | · | 0.99% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B |
| Brüt Kâr Marjı % | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% |
| Faaliyet Kâr Marjı % | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% |
| Net Gelir | $836M | $576M | $542M | $341M | $217M |
| Seyreltilmiş Hisse Başı Kâr | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 |
| Cari Oran | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $1.08B | $631M | $512M | $305M | $53M |
Son Haberler Bu şirketten bahseden son manşetler
İşlem Sinyalleri Giriş fiyatı ve risk/ödül oranı ile son alım/satım sinyalleri
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 1.087 dosya · $16.0B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 131 (-28 önceki Ç'ye göre) | 96 (+4 önceki Ç'ye göre) | 386 (+17 önceki Ç'ye göre) | 352 (+6 önceki Ç'ye göre) | +42.0M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.697.876.797 | 25.209.752 | 10,61% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.323.867.969 | 19.656.540 | 8,27% | Hisse senetleri |
| STATE STREET CORP | $1.237.947.284 | 18.380.806 | 7,73% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $751.533.926 | 11.199.611 | 4,70% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $734.346.085 | 11.693.409 | 4,59% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $545.031.559 | 8.092.525 | 3,41% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $462.914.937 | 6.873.273 | 2,89% | Hisse senetleri |
| NORGES BANK | $462.565.862 | 6.868.090 | 2,89% | Hisse senetleri |
| Castle Hook Partners LP | $260.667.534 | 3.870.342 | 1,63% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $231.614.091 | 3.438.962 | 1,45% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $206.860.340 | 3.071.423 | 1,29% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $162.720.013 | 2.591.083 | 1,02% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $152.790.681 | 2.268.607 | 0,95% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $149.327.006 | 2.217.179 | 0,93% | Hisse senetleri |
| Employees Provident Fund Board | $147.498.453 | 2.190.029 | 0,92% | Hisse senetleri |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $129.989.908 | 2.069.903 | 0,81% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $114.711.656 | 1.703.218 | 0,72% | Hisse senetleri |
| BLAIR WILLIAM & CO/IL | $112.182.565 | 1.665.665 | 0,70% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $109.834.111 | 1.630.796 | 0,69% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $102.869.971 | 1.527.394 | 0,64% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $97.103.277 | 1.441.771 | 0,61% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $93.336.259 | 1.385.802 | 0,58% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $92.130.221 | 1.367.932 | 0,58% | Hisse senetleri |
| DSM CAPITAL PARTNERS LLC | $91.537.742 | 1.359.135 | 0,57% | Hisse senetleri |
| Mitsubishi UFJ Asset Management Co., Ltd. | $89.939.931 | 1.335.411 | 0,56% | Hisse senetleri |
| ROYAL BANK OF CANADA | $88.321.000 | 1.311.368 | 0,55% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $87.360.493 | 1.297.112 | 0,55% | Hisse senetleri |
| CI INVESTMENTS INC. | $86.724.103 | 1.287.663 | 0,54% | Hisse senetleri |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $85.826.193 | 1.274.331 | 0,54% | Hisse senetleri |
| BANK OF NOVA SCOTIA | $85.283.937 | 1.266.285 | 0,53% | Hisse senetleri |
| DNB Asset Management AS | $84.543.377 | 1.255.284 | 0,53% | Hisse senetleri |
| Nearwater Capital Markets, Ltd | $84.187.500 | 1.250.000 | 0,53% | Hisse senetleri |
| Stephens Investment Management Group LLC | $81.126.645 | 1.204.553 | 0,51% | Hisse senetleri |
| Swedbank AB | $78.528.215 | 1.165.972 | 0,49% | Hisse senetleri |
| BlackRock, Inc. | $77.389.460 | 1.149.064 | 0,48% | Hisse senetleri |
| FMR LLC | $77.274.023 | 1.147.350 | 0,48% | Hisse senetleri |
| CITADEL ADVISORS LLC | $75.864.589 | 1.126.423 | 0,47% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $74.838.523 | 1.111.188 | 0,47% | Hisse senetleri |
| HSBC HOLDINGS PLC | $73.861.872 | 1.080.800 | 0,46% | Alım opsiyonu |
| Swiss National Bank | $73.108.425 | 1.085.500 | 0,46% | Hisse senetleri |
| CANADA PENSION PLAN INVESTMENT BOARD | $71.040.241 | 1.054.792 | 0,44% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $67.343.265 | 999.900 | 0,42% | Hisse senetleri |
| CITADEL ADVISORS LLC | $64.656.000 | 960.000 | 0,40% | Satım opsiyonu |
| Legal & General Group Plc | $64.638.083 | 959.734 | 0,40% | Hisse senetleri |
| Sumitomo Mitsui Trust Group, Inc. | $64.478.600 | 957.366 | 0,40% | Hisse senetleri |
| BAILLIE GIFFORD & CO | $63.928.755 | 949.202 | 0,40% | Hisse senetleri |
| CIBC Bancorp USA Inc. | $62.958.645 | 932.286 | 0,39% | Hisse senetleri |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $61.865.555 | 918.568 | 0,39% | Hisse senetleri |
| PRINCIPAL FINANCIAL GROUP INC | $59.044.465 | 876.681 | 0,37% | Hisse senetleri |
| Chicago Capital, LLC | $58.393.062 | 867.009 | 0,36% | Hisse senetleri |
| Fisher Funds Management LTD | $56.637.983 | 840.950 | 0,35% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $56.107.871 | 833.079 | 0,35% | Hisse senetleri |
| JANE STREET GROUP, LLC | $56.062.140 | 832.400 | 0,35% | Alım opsiyonu |
| Bellevue Group AG | $55.394.634 | 822.489 | 0,35% | Hisse senetleri |
| Tri Locum Partners LP | $55.259.261 | 820.479 | 0,35% | Hisse senetleri |
| RHUMBLINE ADVISERS | $51.735.803 | 768.165 | 0,32% | Hisse senetleri |
| ENVESTNET ASSET MANAGEMENT INC | $51.168.667 | 759.743 | 0,32% | Hisse senetleri |
| UBS Group AG | $51.066.858 | 758.231 | 0,32% | Hisse senetleri |
| Allianz Asset Management GmbH | $50.820.963 | 809.251 | 0,32% | Hisse senetleri |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $50.518.000 | 750.088 | 0,32% | Hisse senetleri |
| BARCLAYS PLC | $50.351.331 | 747.607 | 0,31% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $49.968.851 | 741.928 | 0,31% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $49.649.804 | 748.076 | 0,31% | Hisse senetleri |
| Smith Group Asset Management, LLC | $47.235.720 | 701.347 | 0,30% | Hisse senetleri |
| NATIONAL BANK OF CANADA /FI/ | $46.761.576 | 694.307 | 0,29% | Hisse senetleri |
| Assenagon Asset Management S.A. | $46.716.317 | 693.635 | 0,29% | Hisse senetleri |
| NEUBERGER BERMAN GROUP LLC | $46.117.886 | 684.750 | 0,29% | Hisse senetleri |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $44.760.810 | 664.600 | 0,28% | Hisse senetleri |
| PEREGRINE CAPITAL MANAGEMENT LLC | $44.759.530 | 664.581 | 0,28% | Hisse senetleri |
| Capital International Investors | $44.585.633 | 661.999 | 0,28% | Hisse senetleri |
| CAPITAL FUND MANAGEMENT S.A. | $44.543.875 | 661.379 | 0,28% | Hisse senetleri |
| Pictet Asset Management Holding SA | $44.534.379 | 661.238 | 0,28% | Hisse senetleri |
| National Pension Service | $44.471.811 | 660.309 | 0,28% | Hisse senetleri |
| California Public Employees Retirement System | $42.988.899 | 638.291 | 0,27% | Hisse senetleri |
| Korea Investment CORP | $42.608.237 | 632.639 | 0,27% | Hisse senetleri |
| ING GROEP NV | $41.334.513 | 613.727 | 0,26% | Hisse senetleri |
| Susquehanna Portfolio Strategies, LLC | $41.226.753 | 612.127 | 0,26% | Hisse senetleri |
| MIG Capital, LLC | $40.190.154 | 605.547 | 0,25% | Hisse senetleri |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $39.472.718 | 584.004 | 0,25% | Hisse senetleri |
| Quantinno Capital Management LP | $39.303.248 | 583.567 | 0,25% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $36.898.831 | 587.561 | 0,23% | Hisse senetleri |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $36.855.267 | 547.220 | 0,23% | Hisse senetleri |
| FACTORY MUTUAL INSURANCE CO | $36.222.851 | 537.830 | 0,23% | Hisse senetleri |
| Woodline Partners LP | $36.146.880 | 536.702 | 0,23% | Hisse senetleri |
| Parkman Healthcare Partners LLC | $36.016.557 | 534.767 | 0,23% | Hisse senetleri |
| MARSHALL WACE, LLP | $35.884.349 | 532.804 | 0,22% | Hisse senetleri |
| Walleye Trading LLC | $35.823.465 | 531.900 | 0,22% | Alım opsiyonu |
| EVENTIDE ASSET MANAGEMENT, LLC | $33.574.377 | 498.202 | 0,21% | Hisse senetleri |
| Blue Sparrow, LLC /DE | $32.368.410 | 480.600 | 0,20% | Hisse senetleri |
| Trexquant Investment LP | $31.938.380 | 474.215 | 0,20% | Hisse senetleri |
| Cubist Systematic Strategies, LLC | $31.905.647 | 474.151 | 0,20% | Hisse senetleri |
| UBS Group AG | $31.896.960 | 473.600 | 0,20% | Satım opsiyonu |
| Mitsubishi UFJ Trust & Banking Corp | $31.227.164 | 463.655 | 0,20% | Hisse senetleri |
| USS Investment Management Ltd | $30.910.132 | 459.050 | 0,19% | Hisse senetleri |
| OFI INVEST ASSET MANAGEMENT | $29.454.211 | 500.000 | 0,18% | Hisse senetleri |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $29.397.534 | 436.489 | 0,18% | Hisse senetleri |
| ProShare Advisors LLC | $28.566.636 | 424.152 | 0,18% | Hisse senetleri |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $28.528.135 | 427.840 | 0,18% | Hisse senetleri |
| SIRIOS CAPITAL MANAGEMENT L P | $28.315.152 | 420.418 | 0,18% | Hisse senetleri |
| Bridgewater Associates, LP | $27.002.568 | 400.929 | 0,17% | Hisse senetleri |
Şirket yöneticileri 60 içeriden öğrenenler · 36 yöneticiler · 23 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Jacob Steven Leach | President, CEO, and Director | 22 Mayıs 2026 F | 420.359 | 2 | 0 | $1.001.761 |
| Andrew P Rasdal | President & CEO | 02 Mayıs 2006 M | 2.944 | 0 | 0 | $0 |
| Jess Roper | SVP, CFO | 22 Mart 2017 S | 8.452 | 0 | 0 | $0 |
| Steven J Kemper | Chief Financial Officer | 15 Mayıs 2007 A | 26.255 | 0 | 0 | $0 |
| Quentin S. Blackford | Chief Operating Officer | 10 Eylül 2021 S | 19.280 | 0 | 0 | $0 |
| Kevin R Sayer | Executive Chair | 20 Temmuz 2026 S | 328.970 | 0 | 3 | $-5.895.098 |
| Jon Coleman | EVP, Chief Commercial Officer | 04 Haziran 2026 S | 95.450 | 0 | 2 | $-722.628 |
| Sadie Stern | EVP Chief People & Culture Off | 22 Mayıs 2026 F | 130.059 | 0 | 1 | $-117.280 |
| Jereme M Sylvain | EVP, Chief Financal Officer | 22 Mayıs 2026 F | 151.841 | 0 | 1 | $-357.796 |
| Matthew Vincent Dolan | EVP, Strategy & Corporate Dev | 29 Ocak 2025 S | 42.044 | 0 | 0 | $0 |
| Teri L Lawver | EVP Chief Commercial Officer | 12 Mart 2024 S | 66.641 | 0 | 0 | $0 |
| Paul R Flynn | EVP Global Revenue | 18 Aralık 2023 D | 48.949 | 0 | 0 | $0 |
| Barry J. Regan | EVP Operations | 18 Aralık 2023 D | 58.469 | 0 | 0 | $0 |
| Steven Robert Pacelli | EVP Managing Director Dexcom V | 24 Kasım 2023 S | 124.775 | 0 | 0 | $0 |
| Girish Naganathan | EVP Chief Technology Officer | 09 Kasım 2023 S | 47.725 | 0 | 0 | $0 |
| Shelly Ramasamy Selvaraj | SVP Chief Information Officer | 11 Eylül 2023 D | 48.453 | 0 | 0 | $0 |
| Donald Abbey | EVP Global Business Services I | 10 Mart 2023 D | 208.023 | 0 | 0 | $0 |
| Andrew K Balo | EVP Regulatory Strategy Clinic | 10 Mart 2023 D | 50.908 | 0 | 0 | $0 |
| Chad Patterson | EVP Global Marketing | 09 Mayıs 2022 S | 13.675 | 0 | 0 | $0 |
| Sumi Shrishrimal | SVP Chief Risk Officer | 09 Mart 2022 D | 13.789 | 0 | 0 | $0 |
| Patrick Michael Murphy | EVP, Chief Legal Officer | 09 Eylül 2021 S | 16.254 | 0 | 0 | $0 |
| Richard Doubleday | EVP Chief Commercial Officer | 23 Mart 2021 S | 6.654 | 0 | 0 | $0 |
| Jeffrey Moy | EVP Operations | 09 Eylül 2020 D | 34.784 | 0 | 0 | $0 |
| Heather S Ace | SVP Human Resources | 11 Mart 2020 S | 38.584 | 0 | 0 | $0 |
| Terrance H Gregg | Executive Chairman | 16 Temmuz 2018 S | 50.882 | 0 | 0 | $0 |
| John Lister | General Manager, EMEA | 09 Mart 2017 M | 84.034 | 0 | 0 | $0 |
| Peter Gerhardsson | VP, Int'l Bus. Dev. | 16 Kasım 2010 P | 3.387 | 0 | 0 | $0 |
| David Carner | VP, Quality Assurance | 16 Ağustos 2010 A | — | 0 | 0 | $0 |
| Laura Johnson | V.P., Intellectual Property | 12 Mart 2010 A | — | 0 | 0 | $0 |
| Richard Yang | V.P., Strategic Affairs | 12 Mart 2010 A | — | 0 | 0 | $0 |
| Claudia Graham | VP Marketing | 12 Mart 2010 A | 18.741 | 0 | 0 | $0 |
| Rodney L Kellogg | Vice President of Sales | 19 Mayıs 2008 A | — | 0 | 0 | $0 |
| James H Brauker | VP Research & Development | 24 Mart 2008 A | 53.125 | 0 | 0 | $0 |
| Mark Brister | VP, Advanced Development Team | 02 Kasım 2007 A | 10.967 | 0 | 0 | $0 |
| John Riolo | VP of Quality Assurance | 02 Ağustos 2007 A | — | 0 | 0 | $0 |
| Tae Andrews | Vice President of Marketing | 09 Mart 2007 A | — | 0 | 0 | $0 |
| Mark G Foletta | Yönetim kurulu üyesi | 03 Ağustos 2026 S | 48.852 | 0 | 4 | $-627.183 |
| Albert Frederick Osterloh IV | Yönetim kurulu üyesi | 28 Mayıs 2026 A | 8.691 | 0 | 0 | $0 |
| Euan A. Ashley | Yönetim kurulu üyesi | 28 Mayıs 2026 A | 12.731 | 0 | 0 | $0 |
| Rimma Driscoll | Yönetim kurulu üyesi | 28 Mayıs 2026 A | 17.319 | 0 | 0 | $0 |
| Kyle Malady | Yönetim kurulu üyesi | 28 Mayıs 2026 A | 28.242 | 0 | 1 | $-53.934 |
| Richard Alexander Collins | Yönetim kurulu üyesi | 28 Mayıs 2026 A | 5.605 | 0 | 2 | $-389.410 |
| Renee D Gala | Yönetim kurulu üyesi | 28 Mayıs 2026 A | 12.486 | 0 | 0 | $0 |
| Steven R Altman | Yönetim kurulu üyesi | 28 Mayıs 2026 A | 5.565 | 0 | 0 | $0 |
| Karen M Dahut | Yönetim kurulu üyesi | 08 Mayıs 2025 G | 17.779 | 0 | 0 | $0 |
| Eric Topol | Yönetim kurulu üyesi | 08 Mayıs 2025 G | 380.545 | 0 | 0 | $0 |
| Barbara Kahn | Yönetim kurulu üyesi | 18 Mayıs 2024 G | 22.575 | 0 | 0 | $0 |
| Jay S Skyler | Yönetim kurulu üyesi | 18 Mayıs 2023 G | 63.348 | 0 | 0 | $0 |
| Jonathan T Lord MD | Yönetim kurulu üyesi | 01 Eylül 2016 S | 52.820 | 0 | 0 | $0 |
| Martin Doordan | Yönetim kurulu üyesi | 01 Haziran 2012 A | 39.633 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 197 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| TMFM · RBB Fund, Inc. | 5,18% | 81.981 NS | 31 Mayıs 2026 | N-PORT |
| HEAL · Global X Funds | 4,89% | 16.599 NS | 31 Mayıs 2026 | N-PORT |
| SNSR · Global X Funds | 4,74% | 161.491 NS | 31 Mayıs 2026 | N-PORT |
| IHI · iShares Trust | 4,54% | 1.828.483 SH | 08 Ağustos 2026 | Günlük |
| GDOC · Goldman Sachs ETF Trust | 2,79% | 7.621 NS | 31 Mayıs 2026 | N-PORT |
| TMFG · RBB Fund, Inc. | 2,33% | 112.503 NS | 31 Mayıs 2026 | N-PORT |
| AGNG · Global X Funds | 2,01% | 22.316 NS | 31 Mayıs 2026 | N-PORT |
| HRTS · Tema ETF Trust | 1,92% | 13.512 NS | 31 Mayıs 2026 | N-PORT |
| JMID · Janus Detroit Street Trust | 1,91% | 5.848 NS | 30 Nisan 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1,89% | 952 NS | 30 Nisan 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,72% | 158.549 SH | 08 Ağustos 2026 | Günlük |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,42% | 389.654 SH | 08 Ağustos 2026 | Günlük |
| TMFX · RBB Fund, Inc. | 1,37% | 5.955 NS | 31 Mayıs 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,18% | 6.533 NS | 31 Mayıs 2026 | N-PORT |
| MID · AMERICAN CENTURY ETF TRUST | 1,17% | 15.853 NS | 31 Mayıs 2026 | N-PORT |
| DTEC · ALPS ETF Trust | 1,01% | 10.206 NS | 31 Mayıs 2026 | N-PORT |
| QGRO · AMERICAN CENTURY ETF TRUST | 1,01% | 302.231 NS | 31 Mayıs 2026 | N-PORT |
| LGRO · ALPS ETF Trust | 1,00% | 18.376 NS | 31 Mayıs 2026 | N-PORT |
| QQQG · Pacer Funds Trust | 0,99% | 1.867 NS | 30 Nisan 2026 | N-PORT |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 0,97% | 17.329 NS | 30 Nisan 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 0,92% | 6.459 NS | 30 Nisan 2026 | N-PORT |
| MMID · MFS Active Exchange Traded Funds Tr… | 0,91% | 4.208 NS | 31 Mayıs 2026 | N-PORT |
| IWP · iShares Trust | 0,91% | 2.217.346 SH | 08 Ağustos 2026 | Günlük |
| SDG · iShares Trust | 0,87% | 18.232 SH | 08 Ağustos 2026 | Günlük |
| MEDI · Harbor ETF Trust | 0,84% | 3.888 NS | 30 Nisan 2026 | N-PORT |
| QQQE · Direxion Shares ETF Trust | 0,80% | 163.528 NS | 30 Nisan 2026 | N-PORT |
| FWD · AB Active ETFs, Inc. | 0,76% | 296.418 NS | 31 Mayıs 2026 | N-PORT |
| AVMV · AMERICAN CENTURY ETF TRUST | 0,67% | 56.679 NS | 31 Mayıs 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,64% | 1.196 NS | 30 Nisan 2026 | N-PORT |
| QNXT · iShares Trust | 0,59% | 2.014 SH | 08 Ağustos 2026 | Günlük |
| VOT · VANGUARD INDEX FUNDS | 0,57% | 2.956.203 SH | 08 Ağustos 2026 | Günlük |
| IYH · iShares Trust | 0,52% | 229.458 SH | 08 Ağustos 2026 | Günlük |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0,46% | 1.074.035 SH | 08 Ağustos 2026 | Günlük |
| IMCG · iShares Trust | 0,43% | 209.424 SH | 08 Ağustos 2026 | Günlük |
| RXL · ProShares Trust | 0,41% | 4.013 NS | 31 Mayıs 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 0,41% | 2.617 NS | 30 Nisan 2026 | N-PORT |
| IXJ · iShares Trust | 0,40% | 202.443 SH | 08 Ağustos 2026 | Günlük |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,38% | 56.496 NS | 30 Nisan 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,38% | 1.156.710 SH | 08 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,38% | 179.798 NS | 30 Nisan 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,34% | 23.742 SH | 08 Ağustos 2026 | Günlük |
| MMLG · First Trust Exchange-Traded Fund VI… | 0,33% | 4.233 NS | 31 Mayıs 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,33% | 18.233 NS | 31 Mayıs 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,33% | 7.675 NS | 30 Nisan 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,32% | 11.239 NS | 31 Mayıs 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,32% | 9.251 NS | 31 Mayıs 2026 | N-PORT |
| AVLV · AMERICAN CENTURY ETF TRUST | 0,32% | 558.304 NS | 31 Mayıs 2026 | N-PORT |
| TMFE · RBB Fund, Inc. | 0,32% | 3.671 NS | 31 Mayıs 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,30% | 64.292 NS | 30 Nisan 2026 | N-PORT |
| BFOR · ALPS ETF Trust | 0,26% | 7.662 NS | 31 Mayıs 2026 | N-PORT |